GSK Consumer soars 20 pct on parent's open offer plan
MUMBAI (Reuters) - Shares in GlaxoSmithKline Consumer Healthcare (GLSM.NS), the Indian arm of GlaxoSmithKline (GSK.L), surged 20 percent to their maximum daily limit on Monday, following news that its UK-based parent group plans to raise its stake in the unit via an open offer.
GlaxoSmithKline Plc (GSK.L), along with its units, will buy up to 13.39 million shares, or an additional 31.84 percent in GlaxoSmithKline Consumer Healthcare, at 3,900 rupees per share, said HSBC Securities, the manager to the offer, in a statement.
Valued at $2.3 billion, shares in GSK Consumer Healthcare were locked at 3,659.20 rupees, up 20 percent to their maximum daily trading limit, while the Sensex was up 0.42 percent by 9:36 a.m. (Reporting by Kaustubh Kulkarni and Manoj Dharra; Editing by Jijo Jacob)
- Tweet this
- Share this
- Digg this
- Twelve-hour Gaza humanitarian truce takes hold
- Amazon's far-reaching ambitions, lack of profits, unnerve investors |
- India threatens to derail WTO deal, prompts angry U.S. rebuke
- 'Weird Al' Yankovic still trying to wrap head around No. 1 album
- Honda's Mobilio car looks to repeat Indonesia success in India
A 12-hour humanitarian truce went into effect on Saturday after Israel and Palestinian militant groups in the Gaza Strip agreed to a U.N. request for a pause in fighting and efforts proceeded to secure a long-term cease-fire moved ahead. Full Article
Amazon's far-reaching ambitions, lack of profits, unnerve investors Full Article